Cavalcante T

Language: Spanish
References: 25
Page: 549-558
PDF size: 159.55 Kb.

Text Extraction

No abstract

REFERENCES

1. Instituto Brasileiro de Geografia e Estatística, 2000. Censo 2000. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatistica. Disponible en : http://www.ibge.gov.br. [10-09-2003]

2. Ministério da Saúde / Instituto Nacional de Cáncer. Estimativas da incidencia e mortalidade por câncer no Brasil, 2002. Rio de Janeiro: Instituto Nacional de Cáncer; 2002.

3. Pan American Health Organization. Health in the Americas, 2002. Washington, DC: PAHO; 2002.

4. American Cancer Society. Luther Terry awards leadership on tobacco control – Helsinki, 2003. Atlanta (GA): ACS; 2003.

5. Ministério da Saúde / Instituto Nacional de Câncer – Programa Nacional de Controle do Tabagismo e Outros Fatores de Risco de Cáncer – Modelo Lógico e Avaliaçao, 2003. Rio de Janeiro: ING; 2003.

6. Guidon E, Tobin D, Yach D. Trends and affordability of cigarettes prices: Ample room for tax increases and related health gains. Tob Control 2002;11:35-43.

7. Ministério da Saúde / Instituto Nacional de Cáncer (INCA) – Por um mundo livre de tabaco. – Açao Global para Controle do Tabaco: 1º Tratado Internacional de Saúde Pública. 2ª edición, Rio de Janeiro: INC; 2003.

8. Campaign for Tobacco Free Kids & Action on Smoking and Health (Ash). Confíe en nosotros. Somos la industria tabacalera. Washington, DC: National Center for Tobacco Free Kids; 2001.

9. World Health Organization. Confronting the tobacco epidemic in an era of trade liberalization. Ginebra: WHO; 2001. (WHO/NMH/TFI/01.4, 2001).

10. Agencia Nacional de Vigilancia Sanitaria. Derivados del Tabaco/legislación. Rio de Janeiro: Ageˆncia Nacional de Vigilaˆncia Sanitaria. Disponible en: http://www.anvisa.gov.br. [2003 septiembre 10].

11. World Bank. Curbing the epidemic. Governments and the economics of tobacco control. Washington, DC: Banco Mundial; 1999.

12. Ministério da Saúde / Instituto Nacional de Cáncer (INCA). Legislaçao Federal sobre Tabaco no Brasil, atualizado em agosto de 2003. Rio de Janeiro: INCA; 2003. Disponible en: http://www.inca.gov.br/tabaqismo/

13. Kozlowski LT, Pilliteri JL. Beliefs about “light” and “ultra light” cigarettes and efforts to change those beliefs: An overview of early efforts and published research. Tob Control 2001;10 Suppl 1:S4-S11.

14. Pollay RW, Dewhirst T. Marketing cigarettes with low machinemeasured yields. En: Shopland DR, Burns DM, Benowitz NL, Amacher RH, ed. Smoking and tobacco control. Risks associated with smoking cigarettes with low machine- measured yields of tar and nicotine. Bethesda (MD): National Institutes of Health, National Cancer Institute; 2001:199-235. (Monograph 13).

15. Shiffman S, Pilitteri JL, Burton SL et al. Smoker’s beliefs about “Light” and “Ultra Light” cigarettes. Tob Control 2001;10 Suppl 1: Si17-Si23.

16. Koten J. Tobacco marketer’s success formula: Make cigarets [sic] in smoker’s own image. The Wall Street Journal 1980 febrero 29:22.

17. Spears A. Re cost of making tobacco products. Lorillard 1973 noviembre 13.

18. Henningfield JE, Cohen C, Pickworth WB. Psychopharmacology of nicotine. En: Orleans CT, Slade J, comp. Nicotine addiction. Principles and management. Nueva York (NY): Oxford University Press; 1993.

19. Balfour DJ, Fagerström KO. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol Ther 1996;72(1):1-30.

20. Orleans CT, Glynn TJ, Manley MW, Slade J. Minimal–contact quit smoking strategies for medical settings. En: Orleans CT, Slade J, comp. Nicotine addiction. Principles and management. Nueva York (NY): Oxford University Press; 1993.

21. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER et al. Smoking cessation. Smoking Cessation Guideline Panel. En: Clinical Practice Guideline. Rockville (MD): U. S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1996. (Number 18, AHCPR Publication no 96-06292).

22. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER et al. Treating tobacco use and dependence. En: Clinical Practice Guideline. Rockville (MD): U. S. Department of Health and Human Services, Public Health Service, Agency for Heath Care Policy and Research; 2000.

23. Marlatt GA. Prevenção da recaída: racionalidade teórica e visão geral do modelo. En: Marlalt, Gordon, ed. Prevenção de recaída: estratégias de manutenção no tratamento de comportamentos adictivos. Porto Alegre: Artes Médicas Sul; 1993.

24. Figueiredo VC, Szklo M, Szklo AS, Lozana JA, Casado L, Masson E et al. Smoking prevalence in a random sample of the population aged 15 years and older living in Rio de Janeiro, Brazil, 2001. 12th. World Conference on Tobacco or Health; 2003 agosto 3-8; Helsinki, Finland.

25. Gigliotti AP. Hábitos, atitudes e crenças de fumantes em quatro capitais brasileiras: uma comparação com 17 países europeus (tesis). São Paulo: Escola Paulista de Medicina; 2002.